Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
3.76M
-
Shares change
-
+2.47M
-
Total reported value, excl. options
-
$118M
-
Value change
-
+$77.6M
-
Put/Call ratio
-
0
-
Number of buys
-
52
-
Number of sells
-
-11
-
Price
-
$31.35
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2014
74 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q1 2014.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.76M shares
of 22.3M outstanding shares and own 16.9% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (456K shares), DEERFIELD MANAGEMENT CO (372K shares), Consonance Capital Management LP (251K shares), Lombard Odier Asset Management (USA) Corp (250K shares), BlackRock Institutional Trust Company, N.A. (224K shares), KENNEDY CAPITAL MANAGEMENT, INC. (201K shares), VANGUARD GROUP INC (199K shares), CASTLEARK MANAGEMENT LLC (179K shares), First Investors Management Co Inc (144K shares), and Healthcare Value Capital, LLC (134K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.